November 12, 2020
Infectious disease expert Aliza Ayaz explains Pfizer vaccine’s suitability in Pakistan
LONDON: Aliza Ayaz, who is currently studying a master’s degree in Infectious Disease Epidemiology from the prestigious, University College London (UCL) has explained that Pfizer’s vaccine might not be the most suitable for Pakistan. In an exclusive conversation with The Pakistan Daily, the young infectious disease expert said, “This vaccine is good news and it has been announced that this vaccine has a success rate of 90%. However, what needs to be clarified is that Pfizer’s vaccine is still in the preliminary stage. “This is the first stage among three of this vaccine trial which has been tested on over


